Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

BACKGROUND: We developed a novel risk scoring system for urothelial cancer (UC) patients receiving immune checkpoint inhibitors (ICI). METHODS: We conducted a retrospective review of 67 UC patients treated with ICI at Winship Cancer Institute of Emory University from 2015 to 2018. Using stepwise var...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabto, Julie M., Martini, Dylan J., Liu, Yuan, Ravindranathan, Deepak, Brown, Jacqueline, Hitron, Emilie E., Russler, Greta A., Caulfield, Sarah, Kissick, Haydn, Alemozaffar, Mehrdad, Ogan, Kenneth, Harris, Wayne B., Master, Viraj A., Kucuk, Omer, Carthon, Bradley C., Bilen, Mehmet A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163104/
https://www.ncbi.nlm.nih.gov/pubmed/32100417
http://dx.doi.org/10.1002/cam4.2932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163104/
https://www.ncbi.nlm.nih.gov/pubmed/32100417
http://dx.doi.org/10.1002/cam4.2932

Ejemplares similares